Неинфекционное воспалительное поражение аорты и крупных артерий
Неинфекционное воспалительное поражение аорты и крупных артерий
Бекетова Т.В. Неинфекционное воспалительное поражение аорты и крупных артерий. Терапевтический архив. 2022;94(5):695–703. DOI: 10.26442/00403660.2022.05.201500
________________________________________________
Beketova TV. Non-infectious diseases of the aorta and large arteries. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(5):695–703. DOI: 10.26442/00403660.2022.05.201500
Неинфекционное воспалительное поражение аорты и крупных артерий
Бекетова Т.В. Неинфекционное воспалительное поражение аорты и крупных артерий. Терапевтический архив. 2022;94(5):695–703. DOI: 10.26442/00403660.2022.05.201500
________________________________________________
Beketova TV. Non-infectious diseases of the aorta and large arteries. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(5):695–703. DOI: 10.26442/00403660.2022.05.201500
Рассматриваются различные формы воспалительного поражения аорты и крупных артерий, включая хронический периаортит, а также методы их диагностики. К наиболее распространенным относятся васкулиты крупных сосудов, вместе с тем поражение аорты и крупных артерий возможно при различных других ревматических и воспалительных заболеваниях, вследствие лекарственной или паранеопластической реакции. Решающее значение для уточнения фазы болезни и определения тактики лечения принадлежит визуализации с помощью инструментальных методов обследования.
This article describes the various forms of inflammatory lesions of the aorta and large arteries, including chronic periaortitis, as well as the diagnostic methods are considered. Large vessel vasculitis represent the most common entities, however, there is also an association with other rheumatological or inflammatory diseases, drug-induced or paraneoplastic entities. Instrumental imaging modalities play an important role in the diagnosis.
1. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261(2):625-33. DOI:10.1148/radiol.11102250
2. Park SH, Im CH, Yang DH, et al. A case of chronic periaortitis with retroperitoneal fibrosis. Korean Circ J. 2012;42(12):857-60. DOI:10.4070/kcj.2012.42.12.857
3. Fujimori N, Ito T, Igarashi H, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19(1):35-41. DOI:10.3748/wjg.v19.i1.35
4. Rojo-Leyva F, Ratliff NB, Cosgrove III DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43(4):901-7. DOI:10.1002/1529-0131(200004)43:4<901::AIDANR23>3.0.CO;2-U
5. De Martino A, Ballestracci P, Faggioni L, et al. Incidence of aortitis in surgical specimens of the ascending aorta clinical implications at follow-up. Semin Thorac Cardiovasc Surg. 2019;31(4):751-60. DOI:10.1053/j.semtcvs.2018.10.022
6. Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious ascending aortitis: A study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30(9):1150-8. DOI:10.1097/01.pas.0000213293.04026.ec
7. Blockmans D, Ceuninck Ld, Vanderschueren S, et al. Repetitive 18F-fluorodeoxy-glucose positron-emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-7. DOI:10.1002/art.21699
8. Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large-vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636-43. DOI:10.1136/annrheumdis-2017-212649
9. Rosero EB, Peshock RM, Khera A, et al. Sex, race, and age distributions of mean aortic wall thickness in a multiethnic population-based sample. J Vasc Surg. 2011;53(4):950-7. DOI:10.1016/j.jvs.2010.10.073
10. Jennette JC, Falk R, Bacon P, et al. 2012 Revised international Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1-11. DOI:10.1002/art.37715
11. Adiga GU, Elkadi D, Malik SK, et al. Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Investig. 2009;29(12):821-5.
DOI:10.2165/11530790-000000000-00000
12. Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the japanese adverse drug event report database. Cytokine. 2019;119:47-51. DOI:10.1016/j.cyto.2019.02.013
13. Darie C, Boutalba S, Fichter P, et al. Aortite après injections de G-CSF [Aortitis after G-CSF injections]. Rev Med Interne. 2004;25(3):225-9. DOI:10.1016/j.revmed.2003.10.015
14. Koyama Y, Adachi K, Yagi M, et al. Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report. Surg Case Rep. 2021;7:23. DOI:10.1186/s40792-021-01111-z
15. Hiranuma K, Kusunoki S, Fujino K, et al. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57(5):750-2. DOI:10.1016/j.tjog.2018.08.026
16. Tanaka H, Kondo E, Kawato H, et al. Aortitis during intraarterial chemotherapy for cervical cancer. Int J Clin Oncol. 2002;7(1):62-5. DOI:10.1007/s101470200008
17. O’Connell EW, Reams J, Denio AE. Aortitis as a Harbinger of Occult Malignancy. Case Rep Rheumatol. 2019;2019:8385630. DOI:10.1155/2019/8385630
18. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992;7:11-7. DOI:10.1007/BF01744538
19. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-29. DOI:10.7326/0003-4819-120-11-199406010-00004
20. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117(23):3039-51. DOI:10.1161/CIRCULATIONAHA.107.760686
21. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-87. DOI:10.1002/art.1780330804
22. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24(6):422-31. DOI:10.1016/s0049-0172(95)80010-7
23. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48(5):1014-27. DOI:10.1161/01.cir.48.5.1014
24. Hull RG, Asherson RA, Rennie JA. Ankylosing spondylitis and an aortic arch syndrome. Br Heart J. 1984;51(6):663-5. DOI:10.1136/hrt.51.6.663
25. Loricera J, Blanco R, Hernández JL, et al. Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol. 2015;33(2 Suppl. 89):S19-31.
26. Cochrane AD, Tatoulis J. Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg. 1991;52(5):1166-7.
DOI:10.1016/0003-4975(91)91304-e
27. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980;59(6):426-41.
28. Singer O. Cogan and Behcet syndromes. Rheum Dis Clin North Am. 2015;41(1):75-91. DOI:10.1016/j.rdc.2014.09.007
29. Slobodin G, Naschitz JE, Zuckerman E, et al. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol. 2006;24(2 Suppl. 41):41–S47.
30. Giordano M, Valentini G, Sodano A. Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome. Rheumatol Int. 1984;4(4):191-3. DOI:10.1007/BF00541214
31. Manna R, Annese V, Ghirlanda G, et al. Relapsing polychondritis with severe aortic insufficiency. Clin Rheumatol. 1985;4(4):474-80. DOI:10.1007/BF02031904
32. Dib C, Moustafa SE, Mookadam M, et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc. 2006;81(6):772-6. DOI:10.4065/81.6.772
33. Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN. Active aortitis in relapsing polychondritis. J Clin Pathol. 2001;54(11):890-2. DOI:10.1136/jcp.54.11.890
34. Miyake T, Yokoyama T, Shinohara T, et al. Transient dilatation of the abdominal aorta in an infant with Kawasaki disease associated with thrombocytopenia. Acta Paediatr Jpn. 1995;37:521-5. DOI:10.1111/j.1442-200x.1995.tb03368.x
35. Chikamori T, Doi YL, Yonezawa Y, et al. Aortic regurgitation secondary to Behcet’s disease: a case report and review of the literature. Eur Heart J. 1990;11:572-6. DOI:10.1093/oxfordjournals.eurheartj.a059752
36. Willett WF III, Kahn MJ, Gerber MA. Lupus aortitis: a case report and review of the literature. J La State Med Soc. 1996;148:55-9.
37. Guard RW, Gotis-Graham I, Edmonds JP, Thomas AC. Aortitis with dissection complicating systemic lupus erythematosus. Pathology. 1995;27:224-8. DOI:10.1080/00313029500169023
38. Breynaert C, Cornelis T, Stroobants S, et al. Systemic lupus erythematosus complicated with aortitis. Lupus. 2008;17(1):72-4. DOI:10.1177/0961203307084172
39. Kurata A, Kawakami T, Sato J, et al. Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol. 2011;20(1):e1-7. DOI:10.1016/j.carpath.2010.01.003
40. Gravallese EM, Corson JM, Coblyn JS, et al. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine (Baltimore). 1989;68:95-106.
41. Hoshina K, Koyama H, Miyata T, et al. Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. J Vasc Surg. 2004;40(3):512-8. DOI:10.1016/j.jvs.2004.06.018
42. Smith DC, Hirst AE. Spontaneous aortic rupture associated with chronic steroid therapy for rheumatoid arthritis in two cases. AJR Am J Roentgenol. 1979;132(2):271-3. DOI:10.2214/ajr.132.2.271
43. Rose CD, Eichenfield AH, Goldsmith DP, Athreya BH. Early onset sarcoidosis with aortitis – “juvenile systemic granulomatosis?”. J Rheumatol. 1990;17(1):102-6.
44. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med.2012;366(6):539-51. DOI:10.1056/NEJMra1104650
45. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;85(9976):1460-71. DOI:10.1016/S0140-6736(14)60720-0
46. Blockmans D, Baeyens H, Van Loon R, et al. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol. 2000;19(2):161-4. DOI:10.1007/s100670050038
47. Carels T, Verbeken E, Blockmans D. p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report. Clin Rheumatol. 2005;24(1):83-6. DOI:10.1007/s10067-004-0998-0
48. Haug ES, Skomsvoll JF, Jacobsen G, et al. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease.
J Vasc Surg. 2003;38(3):492-7. DOI:10.1016/s0741-5214(03)00340-9
49. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis. A prospective study. Am J Med. 2003;114(6):454-62. DOI:10.1016/s0002-9343(03)00056-1
50. Schirmer M, Duftner C, Seiler R, et al. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis? Curr Opin Rheumatol. 2006;18(1):48-53. DOI:10.1097/01.bor.0000198001.35203.36
51. Ghinoi A, Pipitone N, Boiardi L, et al. Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford). 2007;46(4):719-20. DOI:10.1093/rheumatology/kel452
52. Васильев В.И., Сокол Е.В., Кокосадзе Н.В., и др. Дифференциальная диагностика болезни Эрдгейма–Честера и заболеваний, связанных с IgG4. Терапевтический архив. 2016;88(5):70-6 [Vasilyev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian)]. DOI:10.17116/terarkh201688570-76
53. Inoue M, Nakagomi H, Nakada H, et al. Periaortitis induced by epirubicin and cyclophosphamide for a patient with advanced breast cancer. Int Cancer Conf J. 2017;6(4):180-3. DOI:10.1007/s13691-017-0302-1
54. Murakami S, Saito H, Ohe M, et al. Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapy. Intern Med. 2013;52(5):589-91. DOI:10.2169/internalmedicine.52.6632
55. D’Alpino Peixoto R, Al-Barrak J, Lim H, Renouf D. Gastroesophageal cancer and retroperitoneal fibrosis: two case reports and review of the literature. World J Gastroinest. Oncol. 2013;5(3):68-70. DOI:10.4251/wjgo.v5.i3.68
56. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: A population-based study. Ann Intern Med. 1995;122(7):502-7. DOI:10.7326/0003-4819-122-7-199504010-00004
57. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: A population-based cohort study of the incidence–trends and prognosis. Ann Rheum Dis. 2013;72(12):1989-94. DOI:10.1136/annrheumdis-2012-202408
58. Kim H, Barra L. Ischemic complications in takayasu’s arteritis: A meta-analysis. Semin Arthritis Rheum. 2018;47(6):900-6. DOI:10.1016/j.semarthrit.2017.11.001
59. Sreih AG, Alibaz-Oner F, Kermani TA, et al. Development of a core set of outcome measures for large-vessel vasculitis: Report from OMERACT 2016. J Rheumatol. 2017;44(12):1933-7. DOI:10.3899/jrheum.161467
60. Hunder GG, Bloch DA, Michel BA, et al. The American College of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-8. DOI:10.1002/art.1780330810
61. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron-emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol. 2011;30(10):1265. DOI:10.1007/s10067-011-1828-9
62. Salvarani C, Cantini F, Boiardi L, Hunder G. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21(6 Suppl. 32):23-8.
63. Xenitidis T, Horger M, Zeh G, et al. Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis. Rheumatology (Oxford). 2013;52(9):1729-31. DOI:10.1093/rheumatology/ket107
64. Spira D, Xenitidis T, Henes J, Horger M. MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study. Br J Radiol. 2016;89(1058):20150892. DOI:10.1259/bjr.20150892
65. Benhuri B, ELJack А, Kahaleh B, Chakravarti R. Mechanism and biomarkers in aortitis – a review. J Mol Med. 2020;98(1):11-23. DOI:10.1007/s00109-019-01838-1
66. Diamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. 2014;66:113–9. DOI:10.1002/acr.22178
67. Germanò G, Monti S, Ponte C, et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017;35 Suppl. 103(1):194-98.
68. De Miguel E, Roxo A, Castillo C, et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol. 2012;30:34-8.
69. Habib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol. 2012;31:231-7. DOI:10.1007/s10067-011-1808-0
70. Pipitone N, Versari A, Hunder GG, Salvarani C. Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am. 2013;39:593-608. DOI:10.1016/j.rdc.2013.02.002
71. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol. 2015;27:53-62. DOI:10.1097/BOR.0000000000000130
72. Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Medicine. 2016;95:e4146. DOI:10.1097/MD.0000000000004146
73. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-9. DOI:10.1016/s0002-9343(99)00424-6
74. Puppo C, Massollo M, Paparo F, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. Biomed Res Int. 2014;2014:1-11. DOI:10.1155/2014/574248
75. Bucci M, Aparici CM, Hawkins R, et al. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). J Neuroimaging. 2014;24(2):117-23. DOI:10.1111/j.1552-6569.2012.00740.x
76. Mavrogeni S, Dimitroulas T, Chatziioannou SN, et al. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42:401-12. DOI:10.1016/j.semarthrit.2012.07.005
77. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: State of the art. Best Pract Res Clin Rheumatol. 2016;30(4):688-706.DOI:10.1016/j.berh.2016.09.010
78. Paul JF, Fiessinger JN, Sapoval M, et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr. 2001;25:924-31. DOI:10.1097/00004728-200111000-00015
79. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209:103-9. DOI:10.1148/radiology.209.1.9769819
80. Li D, Lin J, Yan F. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr. 2011;35:468-74. DOI:10.1148/radiology.209.1.9769819
81. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574-8. DOI:10.1002/art.23699
82. Zhang B, Liang L, Chen W, et al. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One. 2015;10:e0129720. DOI:10.1371/journal.pone.0129720
83. Kanda T, Nakai Y, Hagiwara A, et al. Distribution and chemical forms of gadolinium in the brain: a review. Br J Radiol. 2017;90:20170115. DOI:10.1259/bjr.20170115
________________________________________________
1. Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261(2):625-33. DOI:10.1148/radiol.11102250
2. Park SH, Im CH, Yang DH, et al. A case of chronic periaortitis with retroperitoneal fibrosis. Korean Circ J. 2012;42(12):857-60. DOI:10.4070/kcj.2012.42.12.857
3. Fujimori N, Ito T, Igarashi H, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19(1):35-41. DOI:10.3748/wjg.v19.i1.35
4. Rojo-Leyva F, Ratliff NB, Cosgrove III DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43(4):901-7. DOI:10.1002/1529-0131(200004)43:4<901::AIDANR23>3.0.CO;2-U
5. De Martino A, Ballestracci P, Faggioni L, et al. Incidence of aortitis in surgical specimens of the ascending aorta clinical implications at follow-up. Semin Thorac Cardiovasc Surg. 2019;31(4):751-60. DOI:10.1053/j.semtcvs.2018.10.022
6. Miller DV, Isotalo PA, Weyand CM, et al. Surgical pathology of noninfectious ascending aortitis: A study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30(9):1150-8. DOI:10.1097/01.pas.0000213293.04026.ec
7. Blockmans D, Ceuninck Ld, Vanderschueren S, et al. Repetitive 18F-fluorodeoxy-glucose positron-emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-7. DOI:10.1002/art.21699
8. Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large-vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636-43. DOI:10.1136/annrheumdis-2017-212649
9. Rosero EB, Peshock RM, Khera A, et al. Sex, race, and age distributions of mean aortic wall thickness in a multiethnic population-based sample. J Vasc Surg. 2011;53(4):950-7. DOI:10.1016/j.jvs.2010.10.073
10. Jennette JC, Falk R, Bacon P, et al. 2012 Revised international Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1-11. DOI:10.1002/art.37715
11. Adiga GU, Elkadi D, Malik SK, et al. Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Investig. 2009;29(12):821-5.
DOI:10.2165/11530790-000000000-00000
12. Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the japanese adverse drug event report database. Cytokine. 2019;119:47-51. DOI:10.1016/j.cyto.2019.02.013
13. Darie C, Boutalba S, Fichter P, et al. Aortite après injections de G-CSF [Aortitis after G-CSF injections]. Rev Med Interne. 2004;25(3):225-9. DOI:10.1016/j.revmed.2003.10.015
14. Koyama Y, Adachi K, Yagi M, et al. Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report. Surg Case Rep. 2021;7:23. DOI:10.1186/s40792-021-01111-z
15. Hiranuma K, Kusunoki S, Fujino K, et al. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57(5):750-2. DOI:10.1016/j.tjog.2018.08.026
16. Tanaka H, Kondo E, Kawato H, et al. Aortitis during intraarterial chemotherapy for cervical cancer. Int J Clin Oncol. 2002;7(1):62-5. DOI:10.1007/s101470200008
17. O’Connell EW, Reams J, Denio AE. Aortitis as a Harbinger of Occult Malignancy. Case Rep Rheumatol. 2019;2019:8385630. DOI:10.1155/2019/8385630
18. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992;7:11-7. DOI:10.1007/BF01744538
19. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-29. DOI:10.7326/0003-4819-120-11-199406010-00004
20. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117(23):3039-51. DOI:10.1161/CIRCULATIONAHA.107.760686
21. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-87. DOI:10.1002/art.1780330804
22. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24(6):422-31. DOI:10.1016/s0049-0172(95)80010-7
23. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48(5):1014-27. DOI:10.1161/01.cir.48.5.1014
24. Hull RG, Asherson RA, Rennie JA. Ankylosing spondylitis and an aortic arch syndrome. Br Heart J. 1984;51(6):663-5. DOI:10.1136/hrt.51.6.663
25. Loricera J, Blanco R, Hernández JL, et al. Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review. Clin Exp Rheumatol. 2015;33(2 Suppl. 89):S19-31.
26. Cochrane AD, Tatoulis J. Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg. 1991;52(5):1166-7.
DOI:10.1016/0003-4975(91)91304-e
27. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980;59(6):426-41.
28. Singer O. Cogan and Behcet syndromes. Rheum Dis Clin North Am. 2015;41(1):75-91. DOI:10.1016/j.rdc.2014.09.007
29. Slobodin G, Naschitz JE, Zuckerman E, et al. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol. 2006;24(2 Suppl. 41):41–S47.
30. Giordano M, Valentini G, Sodano A. Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome. Rheumatol Int. 1984;4(4):191-3. DOI:10.1007/BF00541214
31. Manna R, Annese V, Ghirlanda G, et al. Relapsing polychondritis with severe aortic insufficiency. Clin Rheumatol. 1985;4(4):474-80. DOI:10.1007/BF02031904
32. Dib C, Moustafa SE, Mookadam M, et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc. 2006;81(6):772-6. DOI:10.4065/81.6.772
33. Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN. Active aortitis in relapsing polychondritis. J Clin Pathol. 2001;54(11):890-2. DOI:10.1136/jcp.54.11.890
34. Miyake T, Yokoyama T, Shinohara T, et al. Transient dilatation of the abdominal aorta in an infant with Kawasaki disease associated with thrombocytopenia. Acta Paediatr Jpn. 1995;37:521-5. DOI:10.1111/j.1442-200x.1995.tb03368.x
35. Chikamori T, Doi YL, Yonezawa Y, et al. Aortic regurgitation secondary to Behcet’s disease: a case report and review of the literature. Eur Heart J. 1990;11:572-6. DOI:10.1093/oxfordjournals.eurheartj.a059752
36. Willett WF III, Kahn MJ, Gerber MA. Lupus aortitis: a case report and review of the literature. J La State Med Soc. 1996;148:55-9.
37. Guard RW, Gotis-Graham I, Edmonds JP, Thomas AC. Aortitis with dissection complicating systemic lupus erythematosus. Pathology. 1995;27:224-8. DOI:10.1080/00313029500169023
38. Breynaert C, Cornelis T, Stroobants S, et al. Systemic lupus erythematosus complicated with aortitis. Lupus. 2008;17(1):72-4. DOI:10.1177/0961203307084172
39. Kurata A, Kawakami T, Sato J, et al. Aortic aneurysms in systemic lupus erythematosus: a meta-analysis of 35 cases in the literature and two different pathogeneses. Cardiovasc Pathol. 2011;20(1):e1-7. DOI:10.1016/j.carpath.2010.01.003
40. Gravallese EM, Corson JM, Coblyn JS, et al. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine (Baltimore). 1989;68:95-106.
41. Hoshina K, Koyama H, Miyata T, et al. Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. J Vasc Surg. 2004;40(3):512-8. DOI:10.1016/j.jvs.2004.06.018
42. Smith DC, Hirst AE. Spontaneous aortic rupture associated with chronic steroid therapy for rheumatoid arthritis in two cases. AJR Am J Roentgenol. 1979;132(2):271-3. DOI:10.2214/ajr.132.2.271
43. Rose CD, Eichenfield AH, Goldsmith DP, Athreya BH. Early onset sarcoidosis with aortitis – “juvenile systemic granulomatosis?”. J Rheumatol. 1990;17(1):102-6.
44. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med.2012;366(6):539-51. DOI:10.1056/NEJMra1104650
45. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;85(9976):1460-71. DOI:10.1016/S0140-6736(14)60720-0
46. Blockmans D, Baeyens H, Van Loon R, et al. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol. 2000;19(2):161-4. DOI:10.1007/s100670050038
47. Carels T, Verbeken E, Blockmans D. p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report. Clin Rheumatol. 2005;24(1):83-6. DOI:10.1007/s10067-004-0998-0
48. Haug ES, Skomsvoll JF, Jacobsen G, et al. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease.
J Vasc Surg. 2003;38(3):492-7. DOI:10.1016/s0741-5214(03)00340-9
49. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis. A prospective study. Am J Med. 2003;114(6):454-62. DOI:10.1016/s0002-9343(03)00056-1
50. Schirmer M, Duftner C, Seiler R, et al. Abdominal aortic aneurysms: an underestimated type of immune-mediated large vessel arteritis? Curr Opin Rheumatol. 2006;18(1):48-53. DOI:10.1097/01.bor.0000198001.35203.36
51. Ghinoi A, Pipitone N, Boiardi L, et al. Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford). 2007;46(4):719-20. DOI:10.1093/rheumatology/kel452
52. Васильев В.И., Сокол Е.В., Кокосадзе Н.В., и др. Дифференциальная диагностика болезни Эрдгейма–Честера и заболеваний, связанных с IgG4. Терапевтический архив. 2016;88(5):70-6 [Vasilyev VI, Sokol EV, Kokosadze NV, et al. The differential diagnosis of Erdheim–Chester disease and IgG4-related diseases. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(5):70-6 (in Russian)]. DOI:10.17116/terarkh201688570-76
53. Inoue M, Nakagomi H, Nakada H, et al. Periaortitis induced by epirubicin and cyclophosphamide for a patient with advanced breast cancer. Int Cancer Conf J. 2017;6(4):180-3. DOI:10.1007/s13691-017-0302-1
54. Murakami S, Saito H, Ohe M, et al. Periaortitis associated with anti-neutrophil cytoplasmic antibodies induced by bevacizumab combination therapy. Intern Med. 2013;52(5):589-91. DOI:10.2169/internalmedicine.52.6632
55. D’Alpino Peixoto R, Al-Barrak J, Lim H, Renouf D. Gastroesophageal cancer and retroperitoneal fibrosis: two case reports and review of the literature. World J Gastroinest. Oncol. 2013;5(3):68-70. DOI:10.4251/wjgo.v5.i3.68
56. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: A population-based study. Ann Intern Med. 1995;122(7):502-7. DOI:10.7326/0003-4819-122-7-199504010-00004
57. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: A population-based cohort study of the incidence–trends and prognosis. Ann Rheum Dis. 2013;72(12):1989-94. DOI:10.1136/annrheumdis-2012-202408
58. Kim H, Barra L. Ischemic complications in takayasu’s arteritis: A meta-analysis. Semin Arthritis Rheum. 2018;47(6):900-6. DOI:10.1016/j.semarthrit.2017.11.001
59. Sreih AG, Alibaz-Oner F, Kermani TA, et al. Development of a core set of outcome measures for large-vessel vasculitis: Report from OMERACT 2016. J Rheumatol. 2017;44(12):1933-7. DOI:10.3899/jrheum.161467
60. Hunder GG, Bloch DA, Michel BA, et al. The American College of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-8. DOI:10.1002/art.1780330810
61. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron-emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol. 2011;30(10):1265. DOI:10.1007/s10067-011-1828-9
62. Salvarani C, Cantini F, Boiardi L, Hunder G. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21(6 Suppl. 32):23-8.
63. Xenitidis T, Horger M, Zeh G, et al. Sustained inflammation of the aortic wall despite tocilizumab treatment in two cases of Takayasu arteritis. Rheumatology (Oxford). 2013;52(9):1729-31. DOI:10.1093/rheumatology/ket107
64. Spira D, Xenitidis T, Henes J, Horger M. MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study. Br J Radiol. 2016;89(1058):20150892. DOI:10.1259/bjr.20150892
65. Benhuri B, ELJack А, Kahaleh B, Chakravarti R. Mechanism and biomarkers in aortitis – a review. J Mol Med. 2020;98(1):11-23. DOI:10.1007/s00109-019-01838-1
66. Diamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. 2014;66:113–9. DOI:10.1002/acr.22178
67. Germanò G, Monti S, Ponte C, et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017;35 Suppl. 103(1):194-98.
68. De Miguel E, Roxo A, Castillo C, et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol. 2012;30:34-8.
69. Habib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol. 2012;31:231-7. DOI:10.1007/s10067-011-1808-0
70. Pipitone N, Versari A, Hunder GG, Salvarani C. Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am. 2013;39:593-608. DOI:10.1016/j.rdc.2013.02.002
71. Prieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol. 2015;27:53-62. DOI:10.1097/BOR.0000000000000130
72. Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Medicine. 2016;95:e4146. DOI:10.1097/MD.0000000000004146
73. Blockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-9. DOI:10.1016/s0002-9343(99)00424-6
74. Puppo C, Massollo M, Paparo F, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. Biomed Res Int. 2014;2014:1-11. DOI:10.1155/2014/574248
75. Bucci M, Aparici CM, Hawkins R, et al. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). J Neuroimaging. 2014;24(2):117-23. DOI:10.1111/j.1552-6569.2012.00740.x
76. Mavrogeni S, Dimitroulas T, Chatziioannou SN, et al. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42:401-12. DOI:10.1016/j.semarthrit.2012.07.005
77. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: State of the art. Best Pract Res Clin Rheumatol. 2016;30(4):688-706.DOI:10.1016/j.berh.2016.09.010
78. Paul JF, Fiessinger JN, Sapoval M, et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr. 2001;25:924-31. DOI:10.1097/00004728-200111000-00015
79. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998;209:103-9. DOI:10.1148/radiology.209.1.9769819
80. Li D, Lin J, Yan F. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. J Comput Assist Tomogr. 2011;35:468-74. DOI:10.1148/radiology.209.1.9769819
81. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574-8. DOI:10.1002/art.23699
82. Zhang B, Liang L, Chen W, et al. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One. 2015;10:e0129720. DOI:10.1371/journal.pone.0129720
83. Kanda T, Nakai Y, Hagiwara A, et al. Distribution and chemical forms of gadolinium in the brain: a review. Br J Radiol. 2017;90:20170115. DOI:10.1259/bjr.20170115
Авторы
Т.В. Бекетова*
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия;
ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента РФ, Москва, Россия;
ФГАОУ ВО «Московский политехнический университет», Москва, Россия
*tvbek@rambler.ru
________________________________________________
Tatiana V. Beketova*
Nasonova Research Institute of Rheumatology, Moscow, Russia;
Central Clinical Hospital with Polyclinic, Moscow, Russia;
Moscow Polytechnic University, Moscow, Russia
*tvbek@rambler.ru